• Accueil >
  • Publications >
  • Bevacizumab Does Not Reduce the Lymphocele Rate in Advanced Ovarian Cancer After Complete Cytoreductive Surgery

Bevacizumab Does Not Reduce the Lymphocele Rate in Advanced Ovarian Cancer After Complete Cytoreductive Surgery

28 mars 2018Anticancer Research

DOI : 10.21873/anticanres.12468